2cureX advances towards IVD-R compliance by securing a contract with a Notified Body2cureX, a company pioneering the use of 3D tumoroids for drug sensitivity prediction in patients with cancer, announced today the signature of a contract with a Notified Body under Regulation (EU) 2017/746 on in vitro diagnostic medi.
Manuel Martin Archuleta | The Pagosa Springs SUN pagosasun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pagosasun.com Daily Mail and Mail on Sunday newspapers.
DIC Asset AG (OTCPK:DDCCF) Q3 2022 Earnings Conference Call November 09, 2022 04:00 AM ET Company Participants Sonja Wärntges - Chief Executive Officer Peer Schlinkmann - Head of Investor.